H.C. Wainwright resumed coverage on Galectin Therapeutics with a new price target

6/17/25 7:49:59 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

H.C. Wainwright resumed coverage of Galectin Therapeutics with a rating of Buy and set a new price target of $6.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$GALT

Date	Price Target	Rating	Analyst
6/17/2025	$6.00	Buy	H.C. Wainwright